Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cis-platinum: a new anticancer agent.

× No keyword cloud information.

21 in total

1. INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE.

Authors: B ROSENBERG; L VANCAMP; T KRIGAS
Journal: Nature Date: 1965-02-13 Impact factor: 49.962

2. Cis-dichlorodiammineplatinum(II) in advanced bladder cancer.

Authors: A Yagoda; R C Watson; J C Gonzalez-Vitale; H Grabstald; W F Whitmore
Journal: Cancer Treat Rep Date: 1976-07

3. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.

Authors: P Kamalakar; A I Freeman; D J Higby; H J Wallace; L F Sinks
Journal: Cancer Treat Rep Date: 1977-08

4. Fluorescent labeling of hormone receptors in viable cells: preparation and properties of highly fluorescent derivatives of epidermal growth factor and insulin.

Authors: Y Shechter; J Schlessinger; S Jacobs; K J Chang; P Cuatrecasas
Journal: Proc Natl Acad Sci U S A Date: 1978-05 Impact factor: 11.205

5. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.

Authors: E Wiltshaw; T Kroner
Journal: Cancer Treat Rep Date: 1976-01

Review 6. Noble metal complexes in cancer chemotherapy.

Authors: B Rosenberg
Journal: Adv Exp Med Biol Date: 1977 Impact factor: 2.622

7. Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.

Authors: J G Krikorian; J R Daniels; B W Brown; M S Hu
Journal: Cancer Treat Rep Date: 1978-10

8. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.

Authors: H W Bruckner; L H Ratner; C J Cohen; R Wallach; B Kabakow; E M Greenspan; J F Holland
Journal: Cancer Treat Rep Date: 1978-07

9. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors: L H Einhorn; J Donohue
Journal: Ann Intern Med Date: 1977-09 Impact factor: 25.391

10. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.

Authors: K K Chary; D J Higby; E S Henderson; K D Swinerton
Journal: Cancer Treat Rep Date: 1977 May-Jun

27 in total

1. Protective role of misoprostol against cisplatin-induced ototoxicity.

Authors: Murat Doğan; Halil Polat; Mehmet Yaşar; Altan Kaya; Ali Bayram; Fatma Şenel; İbrahim Özcan
Journal: Eur Arch Otorhinolaryngol Date: 2016-04-06 Impact factor: 2.503

2. Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity.

Authors: Kumiko Nishihara; Satohiro Masuda; Haruka Shinke; Aiko Ozawa; Takaharu Ichimura; Atsushi Yonezawa; Shunsaku Nakagawa; Ken-Ichi Inui; Joseph V Bonventre; Kazuo Matsubara
Journal: Biochem Pharmacol Date: 2013-01-02 Impact factor: 5.858

Cis-platinum: a new anticancer agent.

1. INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE.

2. Cis-dichlorodiammineplatinum(II) in advanced bladder cancer.

3. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.

4. Fluorescent labeling of hormone receptors in viable cells: preparation and properties of highly fluorescent derivatives of epidermal growth factor and insulin.

5. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.

Review 6. Noble metal complexes in cancer chemotherapy.

7. Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.

8. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.

9. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

10. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.

1. Protective role of misoprostol against cisplatin-induced ototoxicity.

2. Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity.

3. Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin.

4. Does parenteral magnesium sulfate have an antiemetic effect during chemotherapy with cis-platinum?

5. Protective effect of thymoquinone against cisplatin-induced ototoxicity.

6. Combination Cancer Therapy of a Del1 Fragment and Cisplatin Enhanced Therapeutic Efficiency In Vivo.

7. Analysis and treatment of 45 platinum-allergic gynecologic malignant tumors.

8. Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin.

9. Changes in the stria vascularis of the guinea pig due to cis-platinum.

10. Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function.